No significant differences in clinical outcomes were observed between ABP 654 and ustekinumab reference product in patients with plaque psoriasis, including among patients who transitioned from ...
Sixty waterborne disease outbreaks associated with splash pads were reported during 1997 to 2022, according to research published in the Dec. 5 issue of the U.S ...